US2014324025A1PendingUtilityA1

Devices and methods for delivering active agents to the osteomeatal complex

61
Assignee: INTEREST ENT INCPriority: Jul 10, 2006Filed: Jul 9, 2014Published: Oct 30, 2014
Est. expiryJul 10, 2026(expired)· nominal 20-yr term from priority
A61L 31/148A61L 31/08A61P 43/00A61L 31/16A61M 31/00A61K 9/0043
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described here are devices, methods, and kits for treating sinusitis and related respiratory conditions by locally delivering active agents to the osteomeatal complex over a sustained period of time. The devices may be passively fixed within the osteomeatal complex and/or include one or more features that actively fix it within the osteomeatal complex. The devices may optionally include a portion that extends into a sinus ostium, sinus cavity, and/or the nasal passage to deliver an active agent.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for cannulating a portion of an osteomeatal complex comprising:
 securing a portion of a cannulating device to the osteomeatal complex by piercing a portion of the osteomeatal complex with a pointed tip of the cannulating device, wherein the cannulating device comprises a lumen extending at least partially therethrough.   
     
     
         2 . The method of  claim 1  wherein the cannulating device is configured to release one or more active agents. 
     
     
         3 . The method of  claim 2  wherein the one or more active agents comprises an anti-inflammatory agent. 
     
     
         4 . The method of  claim 3  wherein the anti-inflammatory agent comprises mometasone furoate. 
     
     
         5 . The method of  claim 3  wherein the anti-inflammatory agent comprises fluticasone propionate. 
     
     
         6 . The method of  claim 1  wherein the cannulating device comprises a polymer coating. 
     
     
         7 . The method of  claim 6  wherein the polymer coating comprises one or more active agents. 
     
     
         8 . The method of  claim 1  wherein the cannulating device comprises a biodegradable polymer. 
     
     
         9 . The method of  claim 8  wherein the biodegradable polymer comprises a lactide/glycolide polymer. 
     
     
         10 . The method of  claim 1  wherein piercing the portion of the osteomeatal complex comprises piercing an ethmoid bulla. 
     
     
         11 . The method of  claim 1  wherein piercing the portion of the osteomeatal complex comprises piercing an anterior ethmoid cell. 
     
     
         12 . The method of  claim 1  wherein the cannulating device comprises a plurality of openings in a side of the cannulating device, wherein the openings are connected to the lumen. 
     
     
         13 . The method of  claim 1  wherein piercing a portion of the osteomeatal complex comprises piercing an ethmoid bulla and a septum between the ethmoid bulla and an anterior ethmoid cell to create a channel between the ethmoid bulla and the anterior ethmoid cell.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.